An Enduring Mission in a New Era: The FDA Public Health Pillars - U.S. Food and Drug Administration (.gov)

The Seattle Public Library loves to promote books and reading. This monthly column is a space to share reading and book trends from a librarian’s perspective. For Halloween season, these books explore our enduring fascination with monsters in new and surprising ways, from fresh takes on vampire tales to a bestiary that spans time and worlds. Monsters come in many forms and illuminate deeper truths about our fears and even our hopes. Portland author Keith Rosson infuses his horror novels with the sensibility and pacing of crime fiction. “Coffin Moon,” which was recently optioned for TV by Jessica Biel and Paramount, starts in 1975, when Vietnam veteran Duane Minor opens the Last Call Tavern in Portland, unaware that this event will set him on a collision course with John Varley, a vampire born on the gritty Seattle streets a century earlier. When Varley kills Duane's wife, Heidi, Duane and Heidi's adopted 13-year-old niece, Julia, become hellbent on revenge.

Singapore, one of the wealthiest nations in the world, has become the most polluted city on the planet as it chokes under a blanket of thick smog caused by neighboring Indonesia’s wildfires.

Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.